The TSP (Round 2) theme is: Innovative Diagnostic or Monitoring tools for Reproductive and Women’s Health
Reproductive and Women’s health encompasses preconception, antenatal, intrapartum and perinatal care including the wellbeing of both the woman and her baby.
In the UK, despite best efforts in women’s health services, the NHS spends £560 million per year compensating families for negligence during maternity care .
Thus, the introduction of diagnostic and monitoring tools that would improve upon current antenatal healthcare, predict or reduce complications at childbirth, are of great interest to the NHS.
The challenges include accurately stratifying high-risk women during the preconception and antenatal period, screening for prematurity, and predicting unexpected outcomes at birth e.g. stillbirth. Digital tools to improve the well-being of the mother and fetus, via innovative monitoring and diagnostics could support clinical decision making, as well as reduce variability in clinical interpretation.
Other challenges are in finding aids for difficult delivery, timely diagnosis and management of preeclampsia, and the effective management of acute bleeding postpartum. Preconception solutions of interest would include innovative ways to collect and report the reproductive health status of the woman (e.g. hormonal, oxidative stress, micronutrients) measured by a point-of-care or lab-on-chip device.
The TSP (Round 2) is seeking companies that are working in this area and have an innovation, not currently in use in the NHS, which they want to evaluate in an NHS setting.
How to apply: